BIRC5 and glioma: Overall, the prepared DP-CLPs–PTX–siRNA nanocomplex was relatively safe and possessed remarkably targeted therapy of glioma stem cells by combining the chemotherapy of PTX and the small RNA interference effect of survivin siRNA.